| 25.09 13:47 | dpa-AFX: 2seventy, Bristol Myers Discontinue Enrollment In Phase 3 KarMMa-9 Study |
| 25.09 13:13 | dpa-AFX: *2SEVENTY, BRISTOL MYERS TO DISCONTINUE ENROLLMENT IN PHASE 3 KARMMA-9 STUDY |
| 16.09 11:59 | dpa-AFX: *IMMATICS UNVEILS PROMISING PHASE 1 DATA FOR TCER IMA401 TARGETING MAGEA4/8 |
| 10.09 23:51 | dpa-AFX: *BRISTOL-MYERS SQUIBB CO. (BMY) DECLARES QUARTERLY DIVIDEND OF $ 0.60, RECORD DATE 10/4/2024 |
| 06.09 14:34 | dpa-AFX: Bristol-Myers Squibb To Present At Wells Fargo Healthcare Conference; Webcast At 9:30 AM ET |
| 05.09 18:09 | dpa-AFX: Bristol-Myers Squibb To Present At Morgan Stanley Healthcare Conference; Webcast At 1:05 PM ET |
| 05.09 02:59 | dpa-AFX: Merck's Winrevair Approved For Pulmonary Arterial Hypertension In Canada |
| 02.09 04:35 | dpa-AFX: Biotech Stocks Facing FDA Decision In September 2024 |
| 21.08 13:57 | dpa-AFX: Bristol Myers : FDA Accepts SBLA For First-Line Treatment Of Unresectable Hepatocellular Carcinoma |
| 21.08 13:43 | dpa-AFX: *BRISTOL MYERS SQUIBB: FDA ACCEPTS SBLA FOR OPDIVO + YERVOY FOR 1ST-LINE TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA |
| 19.08 16:03 | dpa-AFX: EMA Validates Bristol Myers Squibb's Application For CAR T Cell Therapy Breyanzi |
| 19.08 15:03 | dpa-AFX: *EMA VALIDATES BRISTOL MYERS SQUIBB'S APPLICATION FOR CAR T CELL THERAPY BREYANZI FOR R/R FOLLICULAR LYMPHOMA |
| 16.08 12:28 | MARKT USA/Wall Street nach Rally behauptet erwartet |
| 13.08 08:27 | dpa-AFX: Evotec erhält 75 Millionen Dollar Meilensteinzahlung von Bristol Myers Squibb |
| 13.08 08:27 | Evotec erhält 75 Millionen Dollar Meilensteinzahlung von Bristol Myers Squibb |
| 13.08 08:22 | dpa-AFX: Evotec erhält 75 Millionen Dollar Meilensteinzahlung von Bristol Myers Squibb |
| 13.08 07:59 | Bristol Myers zahlt Evotec 75 Mio Dollar für Fortschritte bei Molecular Glues |
| 13.08 07:52 | dpa-AFX: Evotec Secures $75 Mln In Milestone Payments From Bristol Myers Amid Pipeline Advancements |
| 13.08 07:37 | dpa-AFX: *EVOTEC ANNOUNCES STRONG PROGRESS IN STRATEGIC PROTEIN DEGRADATION PARTNERSHIP WITH BRISTOL MYERS SQUIBB |
| 13.08 07:33 | dpa-AFX: *EVOTEC: LEISTUNGS- UND PROGRAMMABHÄNGIGE ZAHLUNGEN IN HÖHE VON 75 MIO USD |
|
|
